The rapidly spreading Zika virus, implicated in microencephaly, has been found to not cause contamination problems in plasma or urine-derived products, the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has found. The CHMP concluded at its meeting last week that the manufacturing processes for plasma-derived products, including for example the solvent/ detergent method to inactivate viruses, pasteurisation (liquid heat inactivation) and virus filtration, inactivate or remove the Zika virus from the finished product.
Source: Pharmacydaily.com.au, Thursday 22 September 2016